Exicure, Inc. reported a net loss of $4.9 million for the full year 2025, an improvement from a $9.7 million loss in 2024, mainly due to a $6 million gain from early lease termination. The company's cash reserves fell to $3.7 million by the end of 2025 from $12.5 million the previous year, raising concerns about its ability to fund operations for the next 12 months without additional financing. Increased expenses followed the acquisition of GPCR Therapeutics USA Inc., which added $3.3 million in R&D costs and $1.4 million in general and administrative expenses. Exicure is actively exploring strategic alternatives to maximize shareholder value but warns that substantial new funding is critical to sustain its business and pursue these options.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Ethereum (ETH) surged past the $1,894.89 resistance level, accelerating its recovery toward the $1,940–$1,950 zone after days of consolidation. This breakout was supported by lower-than-expected U.S. inflation data, which boosted risk appetite and bu...
Allied Critical Metals announced positive assay results from its 2026 drilling campaign at the Santa Helena Breccia, part of the Borralha Tungsten Project in Portugal. The first drill hole confirmed broad zones of high-grade tungsten mineralization, ...
Ethereum's price rose about 11% over the past week to around $1,920, outperforming major cryptocurrencies like Bitcoin and Solana. This rally is fueled by $96 million inflows into U.S. spot Ether ETFs early in the week, with BlackRock's ETHA product ...
The XRP Ledger has surpassed 8 million activated accounts, marking steady growth since March 2026. However, daily active addresses have declined to a 2026 low of 25,350, indicating less frequent user engagement despite overall adoption. XRP's price f...
